Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.
Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of different doses of metformin on the function of
endothelium in people with pre-diabetes. One group of the patients will receive metformin in
dose: 1500 mg, the second one will receive 3000 mg/day.
The parameters from healthy volunteers will be taken only at the study beginning to compare
the test results with the parameters from patients with pre-diabetes. This group will be not
treated with metformin (no intervention)